Holen Sie sich die Stockscreener-App
5.34
1.52%
0.09
Handel nachbörslich:
5.34
Schlusskurs vom Vortag:
$5.25
Offen:
$5.18
24-Stunden-Volumen:
345.14K
Relative Volume:
0.40
Marktkapitalisierung:
$319.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.80M
KGV:
-7.12
EPS:
-0.75
Netto-Cashflow:
$-30.67M
1W Leistung:
-4.99%
1M Leistung:
-1.11%
6M Leistung:
+151.42%
1J Leistung:
-2.02%
1-Tages-Spanne:
$5.12
$5.36
1-Wochen-Bereich:
$5.12
$5.78
52-Wochen-Spanne:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Firmenname
Aldeyra Therapeutics Inc
Sektor
Branche
Telefon
781-761-4904
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Vergleichen Sie ALDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.34 | 315.24M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-04-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-10-30 | Eingeleitet | Jefferies | Buy |
| 2020-10-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-22 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-05-12 | Eingeleitet | Oppenheimer | Outperform |
| 2018-12-04 | Eingeleitet | Citigroup | Buy |
| 2018-09-26 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Eingeleitet | Janney | Buy |
| 2018-01-26 | Eingeleitet | Seaport Global Securities | Buy |
| 2016-09-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-01 | Eingeleitet | Stifel | Buy |
| 2015-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2015-03-20 | Bestätigt | H.C. Wainwright | Buy |
| 2014-11-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2014-06-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten
Will Aldeyra Therapeutics Inc. stock split again soonEntry Point & High Accuracy Trade Signal Alerts - newser.com
Why analysts upgrade Aldeyra Therapeutics Inc. stock2025 Dividend Review & Verified Entry Point Detection - newser.com
Evaluating Aldeyra Therapeutics Inc. with trendline analysisJuly 2025 Macro Moves & AI Forecasted Stock Moves - newser.com
Risk adjusted return profile for Aldeyra Therapeutics Inc. analyzed2025 Volume Leaders & Growth Focused Entry Reports - newser.com
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Relative strength of Aldeyra Therapeutics Inc. in sector analysis - newser.com
When is the best time to exit Aldeyra Therapeutics Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Statistical indicators supporting Aldeyra Therapeutics Inc.’s strengthInsider Selling & Fast Gain Swing Alerts - newser.com
How to forecast Aldeyra Therapeutics Inc. trends using time seriesTrend Reversal & Consistent Growth Stock Picks - newser.com
Is Aldeyra Therapeutics Inc. stock reversal real or fakeWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals - Benzinga
Analyzing recovery setups for Aldeyra Therapeutics Inc. investorsJuly 2025 Volume & Verified High Yield Trade Plans - newser.com
Jefferies raises Aldeyra Therapeutics stock price target to $7 on FDA acceptance - Investing.com Canada
Aldeyra Therapeutics' (ALDX) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
Will Aldeyra Therapeutics Inc. see short term momentum2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
How to track smart money flows in Aldeyra Therapeutics Inc.Quarterly Profit Review & Short-Term High Return Strategies - newser.com
Is this a good reentry point in Aldeyra Therapeutics Inc.July 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
Using Ichimoku Cloud for Aldeyra Therapeutics Inc. technicalsMarket Weekly Review & Precise Swing Trade Alerts - newser.com
Can Aldeyra Therapeutics Inc. rally from current levels2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
PFG Investments LLC Has $985,000 Holdings in Aldeyra Therapeutics, Inc. $ALDX - MarketBeat
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Multi factor analysis applied to Aldeyra Therapeutics Inc.Quarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
ALDX stock touches 52-week high at $6.6 amid robust annual gains - MSN
High Growth Tech Stocks In The US For September 2025 - simplywall.st
High Growth Tech Stocks In The US Market With Promising Potential - Yahoo Finance
What analysts say about Aldeyra Therapeutics Inc stockFibonacci Extensions & Free Rapid Growing Investment Returns - earlytimes.in
Aldeyra Therapeutics Inc Stock Analysis and ForecastSector ETF Performance & Exceptional Capital Growth - earlytimes.in
Aldeyra Therapeutics Stock Surges on Key Regulatory Advancements - AD HOC NEWS
Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):